Two groups of 20 patients each of Amavata w.s.r. to Rheumatoid Arthritis to be treated with Shunthyadi Kwath along with Baluka Sweda and Mahaushadhi Kwath along with Baluka Sweda to get relief in its symptoms and effect on investigation values

A comparative clinical study to evaluate the efficacy of Shunthyadi Kwath and Mahaushadhi Kwath along with Baluka Sweda in both groups in the management of Amavata w.s.r. to Rheumatoid Arthritis - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/098943

Enrollment

Registered

2025-12-11

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient having sign & symptom of Amavata as mentioned in Madhav Nidan i.e. having atleast 4 symptoms out of these 9 classical symptoms of Sandhisotha, Sandhiruja, Gatrasatabdta, Angamarda, Jwara, Aruchi, Aalasya, Utsaha-hani, Gauravam. 2. Patients of age group between 18 to 60 years. 3. Patients who are ready to give written informed consent. 4. Patients should fulfill the 2010 ACR American College of Rheumatology or EULAR European League Against Rheumatism Criteria criteria for rheumatoid arthritis. 5. Chronicity of disease of at least 3 months and not more than 5 years. 6. Both seropositive & seronegative cases of Amavata

Exclusion criteria

Exclusion criteria: 1. Chronicity of disease is not less than 3 months and more than 5 years. 2. Patients having severe crippling bone deformities, subcutaneous nodules and severely damaged joint with bed ridden patients. 3. Patients diagnosed with malignancy of any system and having active tuberculosis. 4. Patients who are immune-compromised. 5. Patients who are diabetic having HbA1c more than 7.5%. 6. Pregnant women and lactating mother. 7. Any patient with CRF, fatty liver stage 3 and chronic illness of other body organs.

Design outcomes

Primary

Measure	Time frame
The subjective assessment will be done on the basis of improvement in the sign & symptoms given by Acharya Madhavkar in Amavata i.e. A. Pradhan Lakshans (Main signs & Symptoms) Score. I. Sandhi Shoola (joint pain) II.Sandhi Shotha (joint swelling) III. Sandhi stabdata (joint stifness) B. Anubandha Lakshanas (Associate signs & symptoms) I. Angamarda (Bodyache) II. Aruchi (Anorexia) III. Trishna (Thirst) IV. Aalasya (Laziness) V. Jwara (Fever) VI. Apaka (Indigestion) VII. Gaurav (feeling of Heaviness) Timepoint: 30 days	—

Measure

Time frame

The subjective assessment will be done on the basis of improvement in the sign & symptoms given by Acharya Madhavkar in Amavata i.e. A. Pradhan Lakshans (Main signs & Symptoms) Score. I. Sandhi Shoola (joint pain) II.Sandhi Shotha (joint swelling) III. Sandhi stabdata (joint stifness) B. Anubandha Lakshanas (Associate signs & symptoms) I. Angamarda (Bodyache) II. Aruchi (Anorexia) III. Trishna (Thirst) IV. Aalasya (Laziness) V. Jwara (Fever) VI. Apaka (Indigestion) VII. Gaurav (feeling of Heaviness) Timepoint: 30 days

—

Secondary

Measure	Time frame
To assess the objective improvement relevant laboratory investigation like RA factor, CRP, ACCP, etc & the following functional assessment will be done in patients of Amavata. 1. SIMPLE DISEASE ACTIVITY INDEX (SDAI) 2. Patient Global Assessment of Disease Activity [PGA visual analogue scale (VAS) 0-10 cm] 3. Physician Global Assessment of Disease Activity Timepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Vijay Bahadur Singh

Government Ayurvedic College and Hospital

vijay.md09@gmail.com7004642738

Outcome results